Cytochrome c is involved in Fas-mediated apoptosis of prostatic carcinoma cell lines

被引:0
|
作者
Gewies, A
Rokhlin, OW
Cohen, MB
机构
[1] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA
[3] Vet Affairs Med Ctr, Iowa City, IA 52240 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have shown previously that the pathways leading to Fas-mediated apoptosis in prostatic carcinoma cell lines are intact, because apoptosis can be triggered either by Fas ligation alone in the Fas-sensitive cell lines PC3 and ALVA31 or by rendering the Fas-resistant cell lines DU145 and JCA1 Fas-sensitive by combined treatment with anti-Fas monoclonal antibody and cycloheximide (O. W. Rokhlin et al., Cancer Res., 57: 1758-1768, 1997). In this study, we demonstrate that two of the early events after Fas ligation are the release of cytochrome c from the mitochondria and activation of caspase-9. We also found that Bid is processed after Fas ligation and thus might activate the mitochondria-dependent apoptotic cascade. In a cell-free system, cytochrome c induced caspase-3-like activity in cytoplasmic extracts from all four cell lines studied, although differences in the level of enzymatic activity were observed. Western blot analysis revealed that caspase-7 is activated by cytochrome c at the same level in all extracts, whereas expression and activation of caspase-3 varied considerably. Cytochrome c-activated extracts displayed different abilities in the induction of apoptotic features in isolated nuclei such as morphological changes and DNA fragmentation. However, differences in nuclear apoptotic activity induced by cytochrome c did not correlate with the level of caspase-3 like activity in the different extracts. These results suggest that the mitochondrial pathway is involved in Fas-mediated apoptosis in prostatic carcinoma cell lines and that, in addition to caspase-7 and caspase-3, there are other factors that confer nuclear apoptotic activity.
引用
收藏
页码:2163 / 2168
页数:6
相关论文
共 50 条
  • [1] Fas-mediated apoptosis in human prostatic carcinoma cell lines
    Rokhlin, OW
    Bishop, GA
    Hostager, BS
    Waldschmidt, TJ
    Sidorenko, SP
    Pavloff, N
    Kiefer, MC
    Umansky, SR
    Glover, RA
    Cohen, MB
    CANCER RESEARCH, 1997, 57 (09) : 1758 - 1768
  • [2] Mitochondrial retention of cytochrome C in Fas-mediated apoptosis
    Adachi, S
    Gottlieb, RA
    Babior, BM
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 10 - 10
  • [3] Modulation of Fas-mediated apoptosis in osteosarcoma cell lines
    Hamada, T
    Komiya, S
    Yano, H
    Zenmyo, M
    Hiraoka, K
    Inoue, A
    Morimatsu, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (06) : 1125 - 1131
  • [4] Ceramide induces cell death in the human prostatic carcinoma cell lines PC3 and DU145 but does not seem to be involved in Fas-mediated apoptosis
    Gewies, A
    Rokhlin, OW
    Cohen, MB
    LABORATORY INVESTIGATION, 2000, 80 (05) : 671 - 676
  • [5] Bcl-2 modulates Fas-mediated apoptosis in human renal cell carcinoma cell lines
    Hara, I
    Hara, S
    Miyake, H
    Arakawa, S
    Kamidono, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (06) : 1181 - 1185
  • [6] Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7
    Rokhlin, OW
    Glover, RA
    Cohen, MB
    CANCER RESEARCH, 1998, 58 (24) : 5870 - 5875
  • [7] Thyroid carcinoma cells and Fas-mediated apoptosis
    Mitsiades, CS
    Mitsiades, N
    THYROID, 2005, 15 (02) : 178 - 179
  • [8] Loss of function of cytochrome c in Jurkat cells undergoing Fas-mediated apoptosis
    Krippner, A
    MatsunoYagi, A
    Gottlieb, RA
    Babior, BM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (35) : 21629 - 21636
  • [9] Fas-mediated apoptosis
    Nagata, S
    MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION VI: CELL CYCLE AND PROGRAMMED CELL DEATH IN THE IMMUNE SYSTEM, 1996, 406 : 119 - 124
  • [10] Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin
    Wu, XX
    Mizutani, Y
    Kakehi, Y
    Yoshida, O
    Ogawa, O
    CANCER RESEARCH, 2000, 60 (11) : 2912 - 2918